Recently Chinese leading human resource media company HRoot announced its "2023 HRoot Awards in Greater China". Hansoh Pharma was once again honored with the highly-regarded "HRoot Outstanding Employer" award for Greater China, due to its forward-thinking corporate strategy, innovative and digital organization transformation, exceptional corporate social responsibility practices as well as its diverse, fair, and inclusive environment for fostering talent. 

As a leading innovative pharmaceutical enterprise in China, Hansoh Pharma remains committed to pursuing scientific innovation, advancing innovation on all fronts, and managing international talent. Additionally, it focuses on exploring cutting-edge technologies and tackling medical issues, thereby persistently offering high-quality, innovative therapies to patients and creating more clinical value.

To satisfy unmet medical needs, Hansoh Pharma consistently strives to develop new drugs to combat cancer, infections, central nervous system diseases, metabolic disorders, and autoimmune diseases. So far, seven innovative drugs have been approved for the market, and more than 30 innovative drug projects are currently being researched through 40 clinical trials. Notably, there are a number of core drugs which have the potential to become the first or the best in their drug class globally.

Talent is a key driving force for innovation. Hansoh Pharma attaches great importance to cultivating strategy, teamwork, and execution among employees. It also devises a clear dual-channel career development paths focusing on management and professionalism for each team member. Hansoh Pharma puts its best efforts towards building a ladder-type new talent cultivation system, with attractive incentives, an efficient and healthy office environment, and an innovative and dynamic workplace atmosphere. This aims to increase the potential of employees and help them to grow and together create more value with Hansoh Pharma.